PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis.
スポンサーリンク
概要
著者
-
HARADA Katsuhiko
Pharmaceutical Development Laboratory, Kirin Brewery Co., Ltd.
-
IDE Youichi
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd.
-
Yanagida Makoto
Pharmaceutical Development Lab. Kirin Brewery Co. Ltd.
-
Yanagida Makoto
Pharmaceutical Development Laboratory Kirin Brewery Co. Ltd.
-
Imai Atsushi
Pharmaceutical Development Laboratory Kirin Brewery Co. Ltd.
-
Ide Youichi
Pharmaceutical Development Laboratories Development Department Pharmaceutical Division Kirin Brewery
-
Ide Youichi
Pharmaceutical Development Laboratory Kirin Brewery Co. Ltd.
-
Harada Katsuhiko
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Harada Katsuhiko
Pharmaceutical Development Laboratory Kirin Brewery Co. Ltd.
関連論文
- 217 CHRONIC EXPOSURE EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN 6 IN MICE
- Effects of KRN4884 (a Novel K^+ Channel Opener), Leveromakalim, Nilvadipine and Propranolol on Endothelin : 1 : Induced Heart Disorders in Anesthetized Rats
- Involvement of the TGF-β1 Derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and Bone Formation
- PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis.
- Evaluation of lung toxicity using bleomycin-induced lung injury model rat.(GENERAL SESSION BY ORAL PRESENTATION)(GENERAL TOXICITY & NERVOUS SYSTEM)
- PEG-rHuMGDF Causes Osteogenesis by Stimulating Osteoblast Differentiation and Inhibiting Osteoclast Differentiation in Normal Mice
- Effect of KRN2391, a Novel Vasodilator, on Various Experimental Anginal Models in Rats.